Clos P*2/Cl Oth*4/Mor Bovis Kb

Verify with FDA CVM →

26 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
26
Total Reports
24
Deaths Reported
9230.0%
Death Rate

Active Ingredients

Clos P*2/Cl Oth*4/Mor Bovis Kb

Administration Routes

Subcutaneous

Species Affected

Cattle 26

Most Affected Breeds

Crossbred Bovine/Cattle 9
Cattle (other) 9
Red Angus 6
Cattle (unspecified) 1
Aberdeen Angus 1

Most Reported Reactions

Death 20
Found dead 5
Lack of efficacy - NOS 5
Anaphylaxis 4
Lack of efficacy (bacteria) - NOS 4
NT - Abnormal necropsy finding NOS 3
Breathing difficulty 3
Foam in the nose 3
Foam in the mouth 3
Respiratory distress 3
Anaphylactic-type reaction 3
Lateral recumbency 2

Outcome Breakdown

Died
24 (68.6%)
Ongoing
6 (17.1%)
Recovered/Normal
4 (11.4%)
Outcome Unknown
1 (2.9%)

Data Summary

Metric Value
Total adverse event reports 26
Reports involving death 24
Case-fatality rate (reported events) 9230.0%
Distinct species in reports 1
Distinct breeds in reports 5
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Clos P*2/Cl Oth*4/Mor Bovis Kb Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 26 adverse event reports referencing Clos P*2/Cl Oth*4/Mor Bovis Kb, including 24 reports in which the animal died — a 9230.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Clos P*2/Cl Oth*4/Mor Bovis Kb. Reported administration route is Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Clos P*2/Cl Oth*4/Mor Bovis Kb reports are Cattle (26 reports), with Cattle accounting for the largest share. Within those species, Crossbred Bovine/Cattle (9), Cattle (other) (9), Red Angus (6) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Clos P*2/Cl Oth*4/Mor Bovis Kb are Death (20), Found dead (5), Lack of efficacy - NOS (5), Anaphylaxis (4). Of the 35 reports with a coded outcome, Died is the leading category at 68.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Clos P*2/Cl Oth*4/Mor Bovis Kb.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial